Safety in switching from innovator Adalimumab to its biosimilar and from biosimilar to biosimilar. Univ. Sci. [Internet]. 2025 Nov. 5 [cited 2025 Nov. 10];:S24. Available from: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41559